Genmab Financial Overview
Genmab's market cap is currently $19.22B. The company's EPS TTM is $0.646; its P/E ratio is 13.36; Genmab is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $0.43. See an overview of income statement, balance sheet, and cash flow financials.
